Novavax to Present at the 35th Annual J.P. Morgan
Post# of 301275
GAITHERSBURG, Md., Jan. 05, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX ) today announced that management will present at the 35 th Annual J.P. Morgan Healthcare Conference.
Presentation details are as follows:
Date: Thursday, January 12, 2017 Time: 9:30 am U.S. Pacific Time Location: California East room, Westin St. Francis Hotel, San Francisco Live webcast: novavax.com , “Investors”/ “Events”
The webcast and replay of the presentation will also be accessible under the “Investors/Events” section of the website at novavax.com .
About Novavax
Novavax, Inc. (Nasdaq: NVAX ) is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. Our recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. Additional information about Novavax is available on the Company’s website, novavax.com .
Contact: Novavax, Inc. Barclay A. Phillips SVP, Chief Financial Officer and Treasurer Andrea N. Flynn, Ph.D. Associate Director, Investor Relations ir@novavax.com 240-268-2000 Russo Partners, LLC David Schull Todd Davenport, Ph.D. david.schull@russopartnersllc.com todd.davenport@russopartnersllc.com 212-845-4271
(0)
(0)